The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers

Histopathology

Volumn 54, Issue 7, 2009, Pages 820-828

  Jeffery, Natalie ^b   McLean, Mairi H ^a   El Omar, Emad M ^a   Murray, Graeme I ^b,c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Department of Pathology ^*  (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Adenoma; Carcinoma; Colorectal; Immunohistochemistry; Matrix metalloproteinase; Neoplasia

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE POLYP; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM POLYP;

ADENOMA; ADULT; AGED; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; INTESTINAL POLYPS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 66949174829     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03301.x     Document Type: Article

References (39)

1. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 1999 189 300 308. (Pubitemid 29489213)
2. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur. J. Cancer 2000 36 1621 1630. (Pubitemid 30616366)
3. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 2004 16 558 564. (Pubitemid 39201241)
4. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol. 2003 200 448 464. (Pubitemid 36818245)
5. Chirco R, Liu XW, Jung KK, Kim HR. Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev. 2006 25 99 113. (Pubitemid 43723986)
6. Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 2002 21 2245 2252. (Pubitemid 34311378)
7. Jodele S, Blavier L, Yoon JM, DeClerck YA. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev. 2006 25 35 43. (Pubitemid 43723980)
8. Overall CM, Kleifeld O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 2006 6 227 239.
9. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002 2 161 174. (Pubitemid 37328786)
10. Mook OR, Frederiks WM, Van Noorden CJ. The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta 2004 1705 69 89. (Pubitemid 39592897)
11. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006 25 9 34. (Pubitemid 43723979)
12. Fingleton B. Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci. 2006 111 479 491. (Pubitemid 43258157)
13. Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in tumor angiogenesis. Int. J. Cancer 2005 115 849 860. (Pubitemid 40791824)
14. Leeman MF, Curran S, Murray GI. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J. Pathol. 2003 201 528 534. (Pubitemid 38256401)
15. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 1996 2 461 462. (Pubitemid 26191919)
16. Ishikawa T, Ichikawa Y, Mitsuhashi M et al. Matrilysin is associated with progression of colorectal tumour. Cancer Lett. 1996 107 5 10. (Pubitemid 26370851)
17. Adachi Y, Yamamoto H, Itoh F et al. Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int. J. Cancer 2001 95 290 294. (Pubitemid 32847038)
18. Zeng ZS, Huang Y, Cohen AM, Guillem JG. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J. Clin. Oncol. 1996 14 3133 3140. (Pubitemid 26408807)
19. Leeman MF, McKay JA, Murray GI. Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J. Clin. Pathol. 2002 55 758 762. (Pubitemid 35231907)
20. Zeng Z-S, Cohen AM, Zhang ZF, Stetler-Stevenson W, Guillem JG. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin. Cancer Res. 1995 1 899 906.
21. Ring P, Johansson K, Hoyhtya M, Rubin K, Lindmark G. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - a predictor of tumour stage. Br. J. Cancer 1997 76 805 811. (Pubitemid 27379751)
22. Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin. Cancer Res. 2004 10 8229 8234. (Pubitemid 40053382)
23. Lynch CC, Matrisian LM. Matrix metalloproteinases in tumour-host cell communication. Differentiation 2002 70 561 573. (Pubitemid 36194320)
24. Golubkov VS, Strongin AY. Proteolysis-driven oncogenesis. Cell Cycle 2007 6 147 150. (Pubitemid 46232493)
25. Kaplan RN, Rafii S, Lyden D. Preparing the "soil": the premetastatic niche. Cancer Res. 2006 66 11089 11093. (Pubitemid 46009930)
26. Radisky DC, Bissell MJ. Matrix metalloproteinase-induced genomic instability. Curr. Opin. Genet. Dev. 2006 16 45 50. (Pubitemid 43089611)
27. Orlichenko LS, Radisky DC. Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin. Exp. Metastasis 2008 25 593 600.
28. Murray GI, Duncan ME, Arbuckle E, Melvin WT, Fothergil JE. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 1998 43 791 797. (Pubitemid 28539658)
29. Coghlin C, Carpenter B, Dundas SR, Lawrie LC, Telfer C, Murray GI. Characterisation and over-expression of chaperonin T-complex proteins in colorectal cancer. J. Pathol. 2006 210 351 357. (Pubitemid 44660514)
30. McLean MH, Murray GI, Fyfe M, Hold GL, Mowat NAG, El-Omar EM. COX-2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics. Histopathology 2008 52 806 815. (Pubitemid 351724910)
31. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet 2005 365 153 165. (Pubitemid 40091806)
32. Tomita T, Iwata K. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis. Colon Rectum 1996 39 1255 1264. (Pubitemid 26389536)
33. Gimeno-Garcia AZ, Santana-Rodriguez A, Jimenez A et al. Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence. Eur. J. Cancer 2006 42 3246 3252. (Pubitemid 44854506)
34. Malhotra S, Newman E, Eisenberg D et al. Increased membrane type 1 matrix metalloproteinase expression from adenoma to colon cancer: a possible mechanism of neoplastic progression. Dis. Colon Rectum 2002 45 537 543. (Pubitemid 34407733)
35. Kirimlioglu H, Kirimlioglu V, Yilmaz S et al. Role of matrix metalloproteinase-7 in colorectal adenomas. Dig. Dis. Sci. 2006 51 2068 2072. (Pubitemid 44832593)
36. Takeuchi N, Ichikawa Y, Ishikawa T et al. Matrilysin gene expression in sporadic and familial colorectal adenomas. Mol. Carcinog. 1997 19 225 229. (Pubitemid 27392000)
37. Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer 2002 2 657 672. (Pubitemid 37328917)
38. Fingleton B. Matrix metalloproteinases as valid clinical targets. Curr. Pharm. Des. 2007 13 333 346. (Pubitemid 46085282)
39. Wagenaar-Miller RA, Hanley G, Shattuck-Brandt R et al. Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. Br. J. Cancer 2003 88 1445 1452. (Pubitemid 36606430)